Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Mereo BioPharma
Mereo BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?